Gene · 9020
Papers3,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NF-κB-inducing kinase (NIK): an emerging therapeutic target in human disease. | Expert Opin Ther Targets | 2025 | 39918377 | PubTator, text mining | PubMed |
| Exploring MAP3K genes in gastric cancer: biomarkers, tumor microenvironment dynamics, and chemotherapy resistance. | Hereditas | 2025 | 39901302 | PubTator, text mining | PubMed |
| Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation. | J Vis Exp | 2025 | 39878931 | PubTator, text mining | PubMed |
| Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis. | J Neuroinflammation | 2025 | 39856699 | PubTator, text mining | PubMed |
| An overview of small-molecule agents for the treatment of psoriasis. | Bioorg Med Chem | 2025 | 39832444 | PubTator, text mining | PubMed |
| Gene function revealed at the moment of stochastic gene silencing | Commun Biol | 2025 | 39828795 | PubTator, text mining | PubMed |
| Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans. | J Exp Med | 2025 | 39812688 | PubTator, text mining | PubMed |
| IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1. | Biochem Pharmacol | 2025 | 39710275 | PubTator, text mining | PubMed |
| Identification and study of new NF-κB-inducing kinase ligands derived from the imidazolone scaffold. | Arch Pharm (Weinheim) | 2025 | 39604268 | PubTator, text mining | PubMed |
| Lipid Nanoparticle-mRNA Engineered Dendritic Cell Based Adoptive Cell Therapy Enhances Cancer Immune Response. | Small Methods | 2025 | 39039995 | PubTator, text mining | PubMed |
| Discovery of lupus nephritis targeted inhibitors based on De novo molecular design: comprehensive application of vinardo scoring, ADMET analysis, and molecular dynamics simulation. | J Biomol Struct Dyn | 2025 | 38501728 | PubTator, text mining | PubMed |
| [Research progress on molecular mechanism related to skeletal muscle atrophy]. | Sheng Li Xue Bao | 2024 | 39780580 | PubTator, text mining | PubMed |
| Identification of Marine Compounds Inhibiting NF-κBInducing Kinase Through Molecular Docking and Molecular Dynamics Simulations. | Biomolecules | 2024 | 39766197 | PubTator, text mining | PubMed |
| New insights into SUMOylation and NEDDylation in fibrosis. | Front Pharmacol | 2024 | 39697538 | PubTator, text mining | PubMed |
| NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter's Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics. | Genes (Basel) | 2024 | 39596634 | PubTator, text mining | PubMed |
| Lutein, a versatile carotenoid: Insight on neuroprotective potential and recent advances. | Phytomedicine | 2024 | 39531935 | PubTator, text mining | PubMed |
| Evaluation of a plasma cell-free DNA methylation test for colorectal cancer diagnosis: a multicenter clinical study. | BMC Med | 2024 | 39379942 | PubTator, text mining | PubMed |
| Computational recognition of regulator genes and signature for ferroptosis with implications on immunological properties and clinical management of atopic dermatitis. | Front Immunol | 2024 | 39308857 | PubTator, text mining | PubMed |
| The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression. | Biomedicines | 2024 | 39200219 | PubTator, text mining | PubMed |
| Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma. | Liver Int | 2024 | 39164890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9020/papers?page=5